180 related articles for article (PubMed ID: 18167621)
1. Cardiotoxicity and anthracyclines.
Stebbing J; Jones A; Barrett-Lee P
Breast Cancer Res Treat; 2008 Feb; 107(3):451-3. PubMed ID: 18167621
[No Abstract] [Full Text] [Related]
2. [One case report of a late cardiotoxicity after administration of low doses of anthracyclines].
Lawson L; Masmoudi K; Fry P; Andrejak M
Therapie; 2010; 65(3):269-70. PubMed ID: 20699083
[No Abstract] [Full Text] [Related]
3. [Diagnostic possibilities of late cardiotoxic sequelae of chemotherapy with anthracyclines].
Elbl L; Hrstková H; Chaloupka V; Novotný J
Vnitr Lek; 2002 Oct; 48(10):981-8. PubMed ID: 16737150
[TBL] [Abstract][Full Text] [Related]
4. Genotyping the risk of anthracycline-induced cardiotoxicity.
Deng S; Wojnowski L
Cardiovasc Toxicol; 2007; 7(2):129-34. PubMed ID: 17652817
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides in anthracycline-induced cardiotoxicity.
Perik PJ; van Veldhuisen DJ; Gietema JA
Eur J Heart Fail; 2005 Aug; 7(5):940-1; author reply 941. PubMed ID: 16048743
[No Abstract] [Full Text] [Related]
6. [An interpretation of expert panel consensus statement on prevention and treatment of anthracycline cardiotoxicity].
;
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):727-8. PubMed ID: 22339843
[No Abstract] [Full Text] [Related]
7. An introduction to the metabolic determinants of anthracycline cardiotoxicity.
Menna P; Recalcati S; Cairo G; Minotti G
Cardiovasc Toxicol; 2007; 7(2):80-5. PubMed ID: 17652809
[TBL] [Abstract][Full Text] [Related]
8. Managing anthracycline-induced cardiotoxicity: beginning with the end in mind.
Salvatorelli E; Menna P; Minotti G
Future Cardiol; 2015 Jul; 11(4):363-6. PubMed ID: 26239550
[No Abstract] [Full Text] [Related]
9. Role of anthracyclines in the era of targeted therapy.
Cortés-Funes H; Coronado C
Cardiovasc Toxicol; 2007; 7(2):56-60. PubMed ID: 17652804
[TBL] [Abstract][Full Text] [Related]
10. [Late-onset anthracycline-induced cardiotoxicity].
Pérez C; Agustí MA; Tornos P
Med Clin (Barc); 2009 Sep; 133(8):311-3. PubMed ID: 19501849
[No Abstract] [Full Text] [Related]
11. [Prevention of cardiotoxic effects of anthracyclines in oncopediatric praxis].
Safonova SA; Gershanovich ML; Punanov IuA
Vopr Onkol; 2006; 52(5):590-2. PubMed ID: 17168373
[No Abstract] [Full Text] [Related]
12. Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma.
Perel RD; Slaughter RE; Strugnell WE
J Cardiovasc Magn Reson; 2006; 8(6):789-91. PubMed ID: 17060100
[TBL] [Abstract][Full Text] [Related]
13. Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
van den Berg MP; van Spaendonck-Zwarts KY; van Veldhuisen DJ; Gietema JA; Postma A; van Tintelen JP
Eur J Heart Fail; 2010 Dec; 12(12):1297-9. PubMed ID: 20952769
[No Abstract] [Full Text] [Related]
14. Monitoring of anthracycline-induced cardiotoxicity.
Jannazzo A; Hoffman J; Lutz M
Ann Pharmacother; 2008 Jan; 42(1):99-104. PubMed ID: 18094345
[TBL] [Abstract][Full Text] [Related]
15. Cardiac safety of liposomal anthracyclines.
Batist G
Cardiovasc Toxicol; 2007; 7(2):72-4. PubMed ID: 17652807
[TBL] [Abstract][Full Text] [Related]
16. Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer.
Guenancia C; Ladoire S; Ghiringelli F; Rochette L; Vergely C; Cottin Y
Arch Cardiovasc Dis; 2017 Feb; 110(2):69-71. PubMed ID: 28216265
[No Abstract] [Full Text] [Related]
17. Cardiovascular toxicity with cancer chemotherapy.
Frishman WH; Sung HM; Yee HC; Liu LL; Keefe D; Einzig AI; Dutcher J
Curr Probl Cancer; 1997; 21(6):301-60. PubMed ID: 9442980
[No Abstract] [Full Text] [Related]
18. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials.
van Dalen EC; van den Brug M; Caron HN; Kremer LC
Eur J Cancer; 2006 Dec; 42(18):3199-205. PubMed ID: 17011186
[TBL] [Abstract][Full Text] [Related]
19. Role of mtDNA lesions in anthracycline cardiotoxicity.
Lebrecht D; Walker UA
Cardiovasc Toxicol; 2007; 7(2):108-13. PubMed ID: 17652814
[TBL] [Abstract][Full Text] [Related]
20. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors.
Robert J
Cardiovasc Toxicol; 2007; 7(2):135-9. PubMed ID: 17652818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
